Austedo XR 48 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJD8F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $114,153
Award facts
- Contract value 100% obligated
- $114,152.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $114,152.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Austedo XR 48 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract was issued on December 15, 2025, with an ultimate completion date of December 16, 2025, and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. Austedo XR is a medication used to treat tardive dyskinesia and chorea associated with Huntington's disease, reflecting the Defense Logistics Agency Medical Supply Chain's role in providing specialized pharmaceutical products to support military and veteran healthcare systems.
This delivery order operates as a child contract under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp leverages this comprehensive prime contract vehicle to supply an extensive portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's consistent success in competitive federal procurement demonstrates its capability to meet critical medical supply requirements for the Department of Defense and related healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FJD8F?
SPE2DR26FJD8F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FJD8F worth?
The government has obligated $114,153 on SPE2DR26FJD8F.
Is contract SPE2DR26FJD8F an order under another contract?
Yes. SPE2DR26FJD8F is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJD8F competed?
The extent of competition for SPE2DR26FJD8F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award